3.68 USD
↗ 0.15 (4.40%)PRE MARKET (AS OF 07:03 AM EST)
Immuneering Corporation Class A Common Stock (IMRX) trades at $3.68 per share. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, IMRX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 16, 2026.